Microbix Biosystems Inc. (TSE:MBX) Senior Officer Sells C$21,000.00 in Stock

Microbix Biosystems Inc. (TSE:MBX) Senior Officer Philip Jonathan Casselli sold 50,000 shares of the company’s stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of C$0.42, for a total value of C$21,000.00.

Microbix Biosystems Stock Performance

Shares of TSE MBX traded up C$0.09 during midday trading on Wednesday, reaching C$0.52. The company had a trading volume of 1,763,199 shares, compared to its average volume of 303,766. The business’s 50-day simple moving average is C$0.37 and its 200 day simple moving average is C$0.35. The company has a current ratio of 6.62, a quick ratio of 5.57 and a debt-to-equity ratio of 22.68. The stock has a market cap of C$71.08 million, a P/E ratio of 13.00 and a beta of 0.34. Microbix Biosystems Inc. has a 1 year low of C$0.29 and a 1 year high of C$0.52.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.